Healthcare is not typically described as a fast-moving industry. But in 2026, the pace of technology adoption in health systems has accelerated beyond what most observers predicted even three years ago.
The signals are clear. An AMA-backed survey found that 66% of US physicians used AI in clinical practice in 2024, up from 38% in 2023. (Source: American Medical Association, “AMA Digital Health Research: Physician AI Use 2024,” ama-assn.org) Mayo Clinic is mapping over $1 billion in AI investments across more than 200 projects. (Source: Mayo Clinic, “Mayo Clinic AI Strategy,” mayoclinic.org/ai) Digital health funding in the US reached $6.4 billion in the first half of 2025 with AI-enabled startups capturing around 62% of that capital. (Source: Rock Health, “Digital Health Funding Mid-Year Report 2025,” rockhealth.com)
This is no longer an industry debating whether to adopt digital technology. It is an industry managing how fast to adopt it, and which investments will create durable value rather than expensive experiments.
This guide covers the six healthcare technology trends that are generating the most meaningful change in 2026 and what they mean for the organizations building the data infrastructure that makes these advances possible.
Trend 1: AI Is Moving From Documentation Support to Clinical Decision-Making
The first wave of clinical AI was administrative. Ambient scribes tools that listen to doctor-patient conversations and automatically generate clinical notes became widespread adoption targets in 2024 and 2025 because the ROI was simple: physicians spend an estimated two hours documenting for every one hour of direct patient care. (Source: Sinsky, C. et al., “Allocation of Physician Time in Ambulatory Practice,” Annals of Internal Medicine, 2016; corroborated by AMA Physician Practice Benchmark Survey, 2023) Ambient tools return significant portions of that time at low clinical risk.
In 2026, the trajectory is steeper.
AI models are moving into clinical decision support not to replace physician judgement, but to surface patterns in patient data that human review alone would miss. Predictive tools that identify patients at risk of sepsis, deterioration, readmission, or disease progression before clinical symptoms are overt are being integrated into EHR workflows at major health systems.
71% of US hospitals were running at least one EHR-integrated predictive AI tool in 2024, up from 66% in 2023. (Source: American Hospital Association, “AHA Survey on AI Adoption in US Hospitals,” 2024, aha.org) The direction is toward these tools becoming default infrastructure part of standard EHR configurations rather than optional add-ons.
The data challenge behind this trend is significant. Clinical AI models require clean, well-labeled, consistently structured clinical data as inputs. Health systems whose data infrastructure is fragmented or poorly governed are finding that AI projects stall at the data readiness stage rather than the model development stage.
Trend 2: Remote Patient Monitoring Is Becoming a Care Delivery Model
Telemedicine established that care does not have to happen in a clinical facility. Remote patient monitoring (RPM) is extending that shift from episodic video consultations to continuous clinical data collection from patients at home.
The Internet of Medical Things (IoMT) wearables, connected devices, home sensors, implantables generates a continuous stream of biometric data: heart rate, blood pressure, blood glucose, oxygen saturation, activity levels, sleep patterns.
In 2026, this data is being routed into clinical workflows in meaningful ways. AI risk-scoring engines process incoming device data against patient baselines and flag deviations that warrant clinical review before the patient calls the practice, before the next scheduled appointment, before symptoms become a crisis.
For chronic disease management diabetes, hypertension, heart failure, COPD this represents a fundamental shift from reactive to proactive care. The clinical value is clearest where early intervention changes outcomes most dramatically.
The engineering challenge: building the data pipelines that ingest, clean, and contextualize high-frequency IoMT data in ways that are interoperable with EHR systems, compliant with privacy regulations, and clinically actionable rather than merely voluminous.
Trend 3: Precision Medicine Is Moving From Research to Clinical Practice
Precision medicine treatment tailored to the individual based on genetic, proteomic, environmental, and lifestyle data has been a research priority for over a decade.
In 2026, it is beginning to reach clinical practice at scale.
Advances in genomic sequencing have dramatically reduced the cost of sequencing a patient’s genome. AI models trained on large multi-modal clinical datasets are improving the ability to predict which patients will respond to specific treatments and which will experience adverse effects.
Radiopharmaceuticals targeted therapies that deliver treatment to specific cells based on molecular markers represent one of the fastest-growing segments of precision medicine, with several new approvals moving from clinical trials to standard of care.
For data teams, precision medicine requires a fundamentally different data architecture than traditional clinical data management. Genomic data is large, complex, and requires specialist infrastructure to store, process, and analyze.
Linking genomic data to clinical records, outcomes data, and treatment response requires interoperability standards and governance frameworks that most health systems are still building.
Trend 4: Interoperability Is Finally Becoming Operational
Health data interoperability, the ability to share patient data securely across different health systems, providers, payers, and applications has been a stated priority in healthcare for over two decades.
In 2026, regulatory and technical forces are converging to make it genuinely operational.
The European Health Data Space (EHDS) entered force in 2025, mandating data sharing standards across EU member states. In the US, ONC interoperability rules have extended FHIR API requirements to a broader range of health systems and payers.
The result is that data that previously sat in siloed EHR systems is becoming programmatically accessible.
FHIR (Fast Healthcare Interoperability Resources) has emerged as the dominant standard for health data exchange. FHIR APIs allow patient data to flow between systems in a structured, queryable format enabling applications to pull relevant clinical context directly from the EHR rather than requiring manual data entry or proprietary integrations.
This creates significant opportunities for health data engineers. Building the integration layer between FHIR-compliant source systems and analytics platforms, AI models, and care coordination tools is one of the highest-value technical capabilities in health IT right now.
Trend 5: Drug Discovery Is Being Transformed by AI
Traditional pharmaceutical development is slow and expensive. The average drug takes 12 to 15 years and over $2 billion to bring from discovery to market. (Source: Wouters, O.J. et al., “Estimated Research and Development Investment Needed to Bring a New Medicine to Market,” JAMA, 2020; PhRMA, “Biopharmaceutical Research and Development,” phrma.org)
AI is beginning to compress that timeline.
57% of pharmaceutical and biotechnology respondents in the NVIDIA 2026 healthcare AI survey cited drug discovery as one of their primary AI use cases. (Source: NVIDIA, “State of AI in Healthcare and Life Sciences,” 2026, nvidia.com/healthcare)
AI models are being applied to protein structure prediction, molecular property modeling, target identification, and clinical trial design tasks that previously required years of laboratory work and could now be accelerated significantly.
DeepMind’s AlphaFold which predicted the 3D structure of essentially every known protein has been described as one of the most transformative scientific tools of the decade. Its outputs are now widely used by pharmaceutical researchers as a starting point for drug discovery programs. (Source: Jumper, J. et al., “Highly Accurate Protein Structure Prediction with AlphaFold,” Nature, Vol. 596, 2021; DeepMind, “AlphaFold Protein Structure Database,” alphafold.ebi.ac.uk)
In 2026, the frontier is agentic AI systems that can autonomously conduct parts of the discovery process: generating hypotheses, designing experiments, interpreting results, and iterating on candidates without human intervention at each step.
The data challenge is substantial. Training and running these models requires high-quality, well-annotated biological data at a scale that most organizations do not currently have the infrastructure to manage. Partnerships between pharma companies and specialized data organizations are accelerating to fill this gap.
Trend 6: Cybersecurity Has Become a Patient Safety Issue
Healthcare has historically been a high-target, low-defence sector for cybersecurity.
Health systems hold exceptionally sensitive personal data. They operate legacy infrastructure that was not designed with security as a priority. And care delivery systems where system downtime has direct patient safety implications create pressure to pay ransoms that other industries can resist more easily.
In 2026, cybersecurity in healthcare is being reframed not as an IT cost centre but as a patient safety imperative. A ransomware attack that takes a hospital’s clinical systems offline for days is not just a financial event; it directly affects the care patients can receive.
The threat landscape is also evolving. AI-powered attack tools are making sophisticated intrusion attempts accessible to less technically capable threat actors. Healthcare organizations are responding with HITRUST and NIST-aligned security frameworks, zero-trust architecture, and systematic vendor security assessments.
For health data teams specifically, this means that data architecture decisions such as how patient data is stored, who can access it, how it is encrypted in transit and at rest, how access is logged and audited are no longer only governance concerns. They are security and clinical safety concerns.
The Common Thread: Every Trend Runs on Data Infrastructure
These six trends are technically diverse AI scribes, IoMT monitoring, genomic medicine, FHIR APIs, drug discovery models, cybersecurity architectures. But they share a common dependency.
All of them require healthcare organizations to have clean, well-governed, interoperable, and securely managed data at their foundation.
AI clinical decision support is only as reliable as the training data and the real-time inputs it processes. Remote patient monitoring only creates clinical value if device data is correctly integrated with patient records and interpreted in context.
Precision medicine only works if genomic and clinical data can be linked reliably. FHIR APIs only deliver interoperability if the data they expose is consistently structured and trustworthy. Drug discovery AI only accelerates if it is trained on high-quality annotated data.
The organizations that are making the most progress on healthcare technology in 2026 are not the ones with the most advanced AI capabilities on paper. They are the ones that got the data foundations right first.
| Trend | Primary Technology | Core Data Requirement | Engineering Priority |
| Clinical AI | Ambient scribes, predictive models | Clean, structured EHR data with consistent coding | EHR data integration and quality monitoring |
| Remote monitoring | IoMT devices, wearables | High-frequency time-series device data linked to patient records | Streaming pipelines, device data ingestion |
| Precision medicine | Genomics, multi-modal AI | Linked genomic and clinical datasets at scale | Genomic data infrastructure, phenotype linkage |
| Interoperability | FHIR APIs | Standardized data structures across source systems | FHIR API integration, data catalogue coverage |
| Drug discovery AI | LLMs, agentic AI, protein models | Annotated biological datasets, trial outcome data | Research data platforms, annotation workflows |
| Cybersecurity | Zero-trust, AI-aware threat detection | Auditable access logs, encrypted data at rest and in transit | Access control architecture, data lineage for audit |
Final Thoughts
Healthcare is experiencing a technology-driven transformation that is simultaneously clinical, operational, regulatory, and infrastructural.
The limiting factor in most of the trends described here is not the technology itself. It is the data readiness of the organizations trying to deploy it. Healthcare data is historically fragmented across EHR systems, paper records, legacy databases, and siloed departmental applications. Making that data trustworthy, interoperable, and analytically accessible is the foundational work that enables everything else.
For data engineers and data platform teams working in health systems, this is not a background concern, it is the primary constraint that determines how quickly any of these technology trends can deliver clinical and operational value.
If you are building data infrastructure for a healthcare organization whether that is EHR integration pipelines, clinical data warehouses, IoMT data platforms, or governance frameworks for AI-ready data, Data Pilot’s data strategy and engineering consulting is designed to help teams build the foundations that make health technology investments deliver.